These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 323460)

  • 21. Stereoselective serum protein binding of ketoprofen in liver diseases.
    Sakai T; Maruyama T; Sako T; Ahmed S; Zuidema X; Fujiyama S; Otagiri M
    Enantiomer; 1999; 4(5):477-82. PubMed ID: 10586515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma drug binding: implications for anesthesiologists.
    Wood M
    Anesth Analg; 1986 Jul; 65(7):786-804. PubMed ID: 3087239
    [No Abstract]   [Full Text] [Related]  

  • 23. Alterations in reserve bilirubin binding capacity of albumin by free fatty acids. II. In vitro and in vivo studies using difference spectroscopy.
    Whitington PF; Burckart GJ; Gross SR; Korones SB; Helms RA
    J Pediatr Gastroenterol Nutr; 1982; 1(4):495-501. PubMed ID: 7186064
    [No Abstract]   [Full Text] [Related]  

  • 24. Binding of 3-carbethoxipsoralen to human serum albumin and human serum: influence of free fatty acids.
    Font G; Mañes J; Martre H; Prognon P; Mahuzier G
    Rev Esp Fisiol; 1987 Sep; 43(3):317-21. PubMed ID: 3423390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.
    Keller F; Maiga M; Neumayer HH; Lode H; Distler A
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):275-82. PubMed ID: 6519129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug interactions: a therapeutic problem].
    Kahl GF
    Internist (Berl); 1978 Jun; 19(6):366-74. PubMed ID: 352985
    [No Abstract]   [Full Text] [Related]  

  • 27. Embryotoxic drugs.
    Brendel K; Duhamel RC; Shepard TH
    Biol Res Pregnancy Perinatol; 1985; 6(1):1-54. PubMed ID: 2579682
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum protein binding of drugs and bilirubin in newborn infants and their mothers.
    Hamar C; Levy G
    Clin Pharmacol Ther; 1980 Jul; 28(1):58-63. PubMed ID: 7389254
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug interactions through influencing plasma-protein binding].
    Ohnhaus EE
    Internist (Berl); 1979 May; 20(5):225-8. PubMed ID: 376478
    [No Abstract]   [Full Text] [Related]  

  • 30. Drugs and pregnancy.
    Eriksson M; Catz CS; Yaffe SJ
    Clin Obstet Gynecol; 1973 Mar; 16(1):199-224. PubMed ID: 4122730
    [No Abstract]   [Full Text] [Related]  

  • 31. Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors.
    Sjöholm I; Kober A; Odar-Cederlöf I; Borgåa O
    Biochem Pharmacol; 1976 May; 25(10):1205-13. PubMed ID: 938543
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of uremic toxins and nonesterified fatty acids on drug and thyroid hormone binding in serum.
    Lim CF; Stockigt JR
    Clin Chem; 1998 Nov; 44(11):2380-1. PubMed ID: 9799777
    [No Abstract]   [Full Text] [Related]  

  • 33. Albumin binding of bumetanide.
    Robertson A; Karp W
    Dev Pharmacol Ther; 1986; 9(4):241-8. PubMed ID: 3757731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interpretation of protein-drug interaction through fraction bound and relative contribution of secondary sites.
    Mais RF; Keresztes-Nagy S; Zaroslinski JF; Oester YT
    J Pharm Sci; 1974 Sep; 63(9):1423-7. PubMed ID: 4427265
    [No Abstract]   [Full Text] [Related]  

  • 35. [Plasma protein binding. Review].
    von Schwarzenfeld I
    Pharmazie; 1974 Aug; 29(8):497-505. PubMed ID: 4605865
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma drug levels as an aid to medical treatment.
    Fitzgerald DJ; O'Malley K
    Ir Med J; 1984 Jan; 77(1):23-6. PubMed ID: 6363342
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug-protein interaction.
    Krasner J
    Pediatr Clin North Am; 1972 Feb; 19(1):51-63. PubMed ID: 5049219
    [No Abstract]   [Full Text] [Related]  

  • 38. Cicletanine binding to human plasma proteins and erythrocytes, a particular HSA-drug interaction.
    Zini R; Morin D; Jouenne P; Tillement JP
    Life Sci; 1988; 43(25):2103-15. PubMed ID: 3210902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The binding of drugs to plasma proteins from patients with poor renal function.
    Reidenberg MM
    Clin Pharmacokinet; 1976; 1(2):121-5. PubMed ID: 797494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency.
    Pérez-Mateo M; Erill S
    Eur J Clin Pharmacol; 1977 Mar; 11(3):225-31. PubMed ID: 856605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.